American Capital Management’s AngioDynamics ANGO Stock Holding History

American Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-84,000	Closed	-$1.21M	–	95
2016 Q2	$1.21M	Hold	84,000	–	–	0.1%	80
2016 Q1	$1.03M	Hold	84,000	–	–	0.09%	82
2015 Q4	$1.02M	Hold	84,000	–	–	0.09%	82
2015 Q3	$1.11M	Hold	84,000	–	–	0.11%	57
2015 Q2	$1.38M	Hold	84,000	–	–	0.13%	58
2015 Q1	$1.49M	Hold	84,000	–	–	0.15%	58
2014 Q4	$1.6M	Hold	84,000	–	–	0.17%	55
2014 Q3	$1.15M	Hold	84,000	–	–	0.13%	57
2014 Q2	$1.37M	Hold	84,000	–	–	0.15%	59
2014 Q1	$1.32M	Hold	84,000	–	–	0.16%	61
2013 Q4	$1.44M	Hold	84,000	–	–	0.18%	62
2013 Q3	$1.11M	Hold	84,000	–	–	0.15%	65
2013 Q2	$948K	Buy	+84,000	New	+$894K	0.14%	66

Other funds holding ANGO

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

American Capital Management's ANGO Position: Q3 2016 in Review

American Capital Management sold out of AngioDynamics (ANGO) in Q3 2016, closing a stake of 84,000 shares — an estimated $1.21M sold.

American Capital Management first reported a position in ANGO in Q2 2013 and held it in 13 quarters. The position peaked at $1.6M in Q4 2014. 130 funds tracked by Wall St. Rank hold ANGO as of Q3 2016.

American Capital Management reported no remaining AngioDynamics position as of Q3 2016 after selling out during the quarter.
American Capital Management sold 84,000 AngioDynamics shares in Q3 2016, an estimated $1.21M.
American Capital Management first reported a position in AngioDynamics in Q2 2013 and held it in 13 quarters.
American Capital Management's AngioDynamics position peaked at $1.6M in Q4 2014.
130 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2016.

Based on American Capital Management's 13F filing for Q3 2016, filed 26 Oct 2016.